| 1. IDENTIFICATION & BASIC DESCRIPTION |
|
Cohort name
|
| |
COVICAT
|
|
Country
|
| |
|
|
Name
|
| |
Manolis Kogevinas
|
|
Institution
|
| |
ISGlobal
|
|
Email
|
| |
manolis.kogevinas@isglobal.org
|
|
Name
|
| |
Kurt Straif
|
|
Institution
|
| |
ISGlobal
|
|
Email
|
| |
kurt.straif@isglobal.org
|
|
Website
|
| |
- https://www.isglobal.org/en/-/covicat
|
|
Name of committee
|
| |
CEIm Parc de Salut Mar
|
|
Contact Principal Investigator (name)
|
| |
Manolis Kogevinas
|
|
Data access policy (briefly describe)
|
| |
Data access upon request
|
|
Is this cohort part of a consortium? (name consortium)
|
| |
No
|
|
Participation in pooled analyses
|
| |
- The cohort is potentially interested in participating in pooled analyses of (European) occupational cohort studies (note pooled analyses also includes remote decentralized analyses that would not require any transfer of primary data as well as meta-analyses).
|
|
Main aim of cohort, please briefly describe the main objectives of the cohort
|
| |
COVID-19 cohort, with epidemiological information and serology for SARS-CoV-2
|
|
Study design (please select as many as appropriate)
|
| |
|
|
Source population (please select as many as appropriate)
|
| |
- General population: National
- General population: Regional
|
|
Inclusion criteria
|
| |
Cohort composed of previous studies: GCAT, MCC-Spain, ECRHS, Urban Training, INMA, BISC
|
|
Enrollment
|
| |
Completed
|
|
Age range at entry (main cohort)
|
| |
| Minimum |
Maximum |
Mean |
| 15 |
93 |
55 |
|
|
Men at enrollment
|
| |
4139
|
|
Women at enrollment
|
| |
6363
|
|
Children (<18 years) at enrollment
|
| |
273 (INMA)
|
|
Comments
|
| |
COVICAT cohort has used existing studies to contact participants again and ask about the COVID-19 risk factors, in the context of the pandemic.
|
| 2. OUTCOME FOLLOW-UP |
|
Type of data for outcome follow-up (please select as many as appropriate)
|
| |
- Active (contact with participants)
- Hospital / physician diagnoses
|
|
Active (contact with participants) (specify)
|
| |
- We will follow-up the cohort by phone/app/online questionnaires and invite them to participate to the serology test
|
|
Hospital / Physician diagnoses (specify)
|
| |
- Data Analysis Program for Health Research and Innovation (PADRIS) for the GCAT cohort
|
|
First follow-up period (provide year)
|
| |
2021
|
|
Last follow-up period (provide year)
|
| |
2022
|
|
Number of follow-ups after baseline (provide number)
|
| |
0
|
| 3. OCCUPATIONAL EXPOSURES |
|
Source of exposure data collected (please select as many as appropriate)
|
| |
- Questionnaire, Personal (Self-reporting or interview)
- Other (specify)
|
|
Specify: Other
|
| |
blood samples
|
|
Occupational history/time frame
|
| |
Other (specify)
|
|
Specify: Other
|
| |
at enrollment in the original cohort, at enrollment in the COVICAT study, during the lockdown (March-May 2020)
|
|
Occupational coding performed
|
| |
Yes
|
|
Occupation (specify coding system used)
|
| |
|
|
Methods for exposure assessment (please select as many as appropriate)
|
| |
- GIS (other spatial methods)
- Expert assessment
- Measurements (external sampling, biomarkers)
- Self-report
|
| 4. OUTCOMES EVALUATED |
|
Baseline - type of outcome data collected (select more than one if applicable)
|
| |
|
|
Specify: Biomarker
|
| |
SARS-CoV-2 antibodies (IgM, IgA, IgG)
|
|
Outcome type (please select as many as appropriate)
|
| |
|
| 5. BIOLOGICAL SAMPLES & ANALYSIS |
|
Biological samples collected
|
| |
|
|
Genetic and other lab analyses
|
| |
|
|
Specify: Other
|
| |
SARS-CoV-2 antibodies (IgM, IgG, IgA)
|
| 6. Other Information |
|
|
| |
- Alcohol
- Anthropometry
- Demographics
- Education
- Environmental, air pollution
- Environmental other (specify)
- Medical history
- Personality
- Physical exercise
- Residential history
- Socioeconomic status
- Smoking
- Other (specify)
|
|
Specify: Environmental other
|
| |
Green spaces, noise
|
|
Specify: Other
|
| |
COVID-19 symptoms and contacts, social support questionnaire
|
|
Possibility for linkage to data registries/data enrichment via data linkage
|
| |
|
|
Specify: Other
|
| |
PADRIS
|
|
Please describe plans that are funded or most likely to be funded
|
| |
We have only done the baseline, follow-up is planned for beginning 2021
|
